195 related articles for article (PubMed ID: 23842188)
21. Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease.
Brukamp K; Jim B; Moeller MJ; Haase VH
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1397-407. PubMed ID: 17609290
[TBL] [Abstract][Full Text] [Related]
22. Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis.
Henique C; Bollée G; Loyer X; Grahammer F; Dhaun N; Camus M; Vernerey J; Guyonnet L; Gaillard F; Lazareth H; Meyer C; Bensaada I; Legrès L; Satoh T; Akira S; Bruneval P; Dimmeler S; Tedgui A; Karras A; Thervet E; Nochy D; Huber TB; Mesnard L; Lenoir O; Tharaux PL
Nat Commun; 2017 Nov; 8(1):1829. PubMed ID: 29184126
[TBL] [Abstract][Full Text] [Related]
23. Distinct roles for basal and induced COX-2 in podocyte injury.
Cheng H; Fan X; Guan Y; Moeckel GW; Zent R; Harris RC
J Am Soc Nephrol; 2009 Sep; 20(9):1953-62. PubMed ID: 19643929
[TBL] [Abstract][Full Text] [Related]
24. mPGES-1-derived prostaglandin E2 stimulates Stat3 to promote podocyte apoptosis.
Yu J; Wu Y; Wang L; Zhang W; Xu M; Song J; Fu Y; Cui Y; Gong W; Li S; Xia W; Huang S; Zhang A; Jia Z
Apoptosis; 2017 Nov; 22(11):1431-1440. PubMed ID: 28879567
[TBL] [Abstract][Full Text] [Related]
25. Podocyte loss involves MDM2-driven mitotic catastrophe.
Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
[TBL] [Abstract][Full Text] [Related]
26. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
27. Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage.
Zhao Q; Dai H; Jiang H; Zhang N; Hou F; Zheng Y; Gao Y; Liu W; Feng Z; Hu Y; Tang X; Rui H; Liu B
Biomed Pharmacother; 2024 May; 174():116583. PubMed ID: 38626520
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of podocyte FAK protects against proteinuria and foot process effacement.
Ma H; Togawa A; Soda K; Zhang J; Lee S; Ma M; Yu Z; Ardito T; Czyzyk J; Diggs L; Joly D; Hatakeyama S; Kawahara E; Holzman L; Guan JL; Ishibe S
J Am Soc Nephrol; 2010 Jul; 21(7):1145-56. PubMed ID: 20522532
[TBL] [Abstract][Full Text] [Related]
29. Collapsing glomerulopathy: an inflammatory podocytopathy?
Barisoni L; Nelson PJ
Curr Opin Nephrol Hypertens; 2007 May; 16(3):192-5. PubMed ID: 17420661
[TBL] [Abstract][Full Text] [Related]
30. SPARC accelerates disease progression in experimental crescentic glomerulonephritis.
Sussman AN; Sun T; Krofft RM; Durvasula RV
Am J Pathol; 2009 May; 174(5):1827-36. PubMed ID: 19342370
[TBL] [Abstract][Full Text] [Related]
31. The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.
Bideak A; Blaut A; Hoppe JM; Müller MB; Federico G; Eltrich N; Gröne HJ; Locati M; Vielhauer V
Kidney Int; 2018 Apr; 93(4):826-841. PubMed ID: 29395335
[TBL] [Abstract][Full Text] [Related]
32. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
Logar CM; Brinkkoetter PT; Krofft RD; Pippin JW; Shankland SJ
Kidney Int; 2007 Aug; 72(4):489-98. PubMed ID: 17554257
[TBL] [Abstract][Full Text] [Related]
33. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.
Meyer-Schwesinger C; Dehde S; Klug P; Becker JU; Mathey S; Arefi K; Balabanov S; Venz S; Endlich KH; Pekna M; Gessner JE; Thaiss F; Meyer TN
J Immunol; 2011 Sep; 187(6):3218-29. PubMed ID: 21844386
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation.
Yu J; Wu H; Liu ZY; Zhu Q; Shan C; Zhang KQ
Int J Mol Med; 2017 Oct; 40(4):1185-1193. PubMed ID: 28849106
[TBL] [Abstract][Full Text] [Related]
35. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
[TBL] [Abstract][Full Text] [Related]
36. IL-6/STAT3 signaling activation exacerbates high fructose-induced podocyte hypertrophy by ketohexokinase-A-mediated tristetraprolin down-regulation.
Zhou J; Yang J; Wang YM; Ding H; Li TS; Liu ZH; Chen L; Jiao RQ; Zhang DM; Kong LD
Cell Signal; 2021 Oct; 86():110082. PubMed ID: 34252535
[TBL] [Abstract][Full Text] [Related]
37. ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation.
Korte EA; Caster DJ; Barati MT; Tan M; Zheng S; Berthier CC; Brosius FC; Vieyra MB; Sheehan RM; Kosiewicz M; Wysoczynski M; Gaffney PM; Salant DJ; McLeish KR; Powell DW
Am J Pathol; 2017 Dec; 187(12):2799-2810. PubMed ID: 28935578
[TBL] [Abstract][Full Text] [Related]
38. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
39. Novel therapeutic perspectives for crescentic glomerulonephritis through targeting parietal epithelial cell activation and proliferation.
Huang Y; Zhao X; Zhang Q; Yang X; Hou G; Peng C; Jia M; Zhou L; Yamamoto T; Zheng J
Expert Opin Ther Targets; 2023 Jan; 27(1):55-69. PubMed ID: 36738160
[TBL] [Abstract][Full Text] [Related]
40. Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice.
Woychyshyn B; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1377-F1390. PubMed ID: 32308020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
